110 related articles for article (PubMed ID: 19767767)
1. A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia.
Li QB; Li L; You Y; Chen ZC; Xia LH; Zou P
Acta Pharmacol Sin; 2009 Oct; 30(10):1471-8. PubMed ID: 19767767
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of allogeneic hematopoietic stem cell transplantation based on a total body irradiation conditioning treatment regimen for adult acute lymphocytic leukemia].
Xiao QQ; Yu XL; Song XC; Hou YX; Deng L; Li WJ; Zhou F
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):249-256. PubMed ID: 38716596
[No Abstract] [Full Text] [Related]
3. Effect of Conditioning Regimens and Graft-versus-Host Disease Prophylaxis on the Outcomes of Umbilical Cord Blood Transplantation Performed with Cyclophosphamide/Total Body Irradiation-Based Regimens.
Imahashi N; Kurita N; Konuma T; Takahashi S; Nishida T; Tanaka M; Nakamae H; Kawakita T; Ota S; Doki N; Onishi Y; Sawa M; Ozeki K; Hiramoto N; Onizuka M; Ishimaru F; Ichinohe T; Atsuta Y; Kanda J
Transplant Cell Ther; 2024 Mar; 30(3):318.e1-318.e11. PubMed ID: 38081416
[TBL] [Abstract][Full Text] [Related]
4. The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia.
Holter-Chakrabarty JL; Pierson N; Zhang MJ; Zhu X; Akpek G; Aljurf MD; Artz AS; Baron F; Bredeson CN; Dvorak CC; Epstein RB; Lazarus HM; Olsson RF; Selby GB; Williams KM; Cooke KR; Pasquini MC; McCarthy PL
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1251-7. PubMed ID: 25840335
[TBL] [Abstract][Full Text] [Related]
5. Intensified conditioning regimens with total marrow irradiation/etoposide/cyclophosphamide and busulfan/etoposide/cyclophosphamide overcome the impact of pre-transplant minimal residual disease on outcomes in high-risk acute lymphoblastic leukemia patients in complete remission.
Zhao X; Xu Z; Li Z; Zhou X; Hu Y; Wang H
Cancer Med; 2024 Jan; 13(1):. PubMed ID: 38164654
[TBL] [Abstract][Full Text] [Related]
6. Thiotepa-Based Regimens Are Valid Alternatives to Total Body Irradiation-Based Reduced-Intensity Conditioning Regimens in Patients with Acute Lymphoblastic Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Battipaglia G; Labopin M; Mielke S; Ruggeri A; Nur Ozkurt Z; Bourhis JH; Rabitsch W; Yakoub-Agha I; Grillo G; Sanz J; Arcese W; Novis Y; Fegueux N; Spyridonidis A; Giebel S; Nagler A; Ciceri F; Mohty M
Transplant Cell Ther; 2024 Jan; 30(1):95.e1-95.e10. PubMed ID: 37816471
[TBL] [Abstract][Full Text] [Related]
7. In Vivo T Cell Depletion with Myeloablative Regimens on Outcomes after Cord Blood Transplantation for Acute Lymphoblastic Leukemia in Children.
Ponce DM; Eapen M; Sparapani R; O'Brien TA; Chan KW; Chen J; Craddock J; Schultz KR; Wagner JE; Perales MA; Barker JN
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2173-2179. PubMed ID: 26327630
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Pulmonary Toxicity after Total Body Irradiation- and Busulfan-Based Myeloablative Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients.
Liu KX; Poux N; Shin KY; Moore N; Chen YH; Margossian S; Whangbo JS; Duncan CN; Lehmann LE; Marcus KJ
Transplant Cell Ther; 2022 Aug; 28(8):502.e1-502.e12. PubMed ID: 35623615
[TBL] [Abstract][Full Text] [Related]
9. CLAG combined with total body irradiation as intensive conditioning chemotherapy prior to allogeneic hematopoietic stem cell transplantation in patients with refractory or relapsed acute myeloid leukemia.
Fei X; Zhang W; Gu J; Yang F; Li T; Wang W; Wang J
Ann Hematol; 2024 Jan; 103(1):241-249. PubMed ID: 37847380
[TBL] [Abstract][Full Text] [Related]
10. TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia.
Ueki H; Ogawa C; Goto H; Nishi M; Yamanaka J; Mochizuki S; Nishikawa T; Kumamoto T; Nishiuchi R; Kikuta A; Yamamoto S; Igarashi S; Sato A; Hori T; Saito AM; Watanabe T; Deguchi T; Manabe A; Horibe K; Toyoda H
Int J Hematol; 2024 Apr; 119(4):450-458. PubMed ID: 38267673
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic Stem Cell Transplant for Acute Myeloid Leukemia: Evolution of an Effective Strategy in India.
Ganapule A; Nemani S; Korula A; Lakshmi KM; Abraham A; Srivastava A; Balasubramanian P; George B; Mathews V
J Glob Oncol; 2017 Dec; 3(6):773-781. PubMed ID: 29244983
[TBL] [Abstract][Full Text] [Related]
12. The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update.
Zhang XH; Chen J; Han MZ; Huang H; Jiang EL; Jiang M; Lai YR; Liu DH; Liu QF; Liu T; Ren HY; Song YP; Sun ZM; Tang XW; Wang JM; Wu DP; Xu LP; Zhang X; Zhou DB; Huang XJ
J Hematol Oncol; 2021 Sep; 14(1):145. PubMed ID: 34526099
[TBL] [Abstract][Full Text] [Related]
13. Medium-dose etoposide, cyclophosphamide and total body irradiation conditioning potentiates anti-leukemia immunity in adults with acute lymphoblastic leukemia without aggravating graft-versus-host disease.
Imamura M
Cytotherapy; 2023 Dec; 25(12):1251-1258. PubMed ID: 37665303
[TBL] [Abstract][Full Text] [Related]
14. Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation.
Cutler C; Stevenson K; Kim HT; Richardson P; Ho VT; Linden E; Revta C; Ebert R; Warren D; Choi S; Koreth J; Armand P; Alyea E; Carter S; Horowitz M; Antin JH; Soiffer R
Blood; 2008 Dec; 112(12):4425-31. PubMed ID: 18776081
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: Who, When, and How?
Loke J; Buka R; Craddock C
Front Immunol; 2021; 12():659595. PubMed ID: 34012445
[TBL] [Abstract][Full Text] [Related]
16. The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology.
Xu L; Chen H; Chen J; Han M; Huang H; Lai Y; Liu D; Liu Q; Liu T; Jiang M; Ren H; Song Y; Sun Z; Wang J; Wu D; Zhou D; Zou P; Liu K; Huang X
J Hematol Oncol; 2018 Mar; 11(1):33. PubMed ID: 29495966
[TBL] [Abstract][Full Text] [Related]
17. Graft failure after allogeneic hematopoietic stem cell transplantation in pediatric patients with acute leukemia: autologous reconstitution or second transplant?
Rostami T; Rostami MR; Mirhosseini AH; Mohammadi S; Nikbakht M; Alemi H; Khavandgar N; Rad S; Janbabai G; Mousavi SA; Kiumarsi A; Kasaeian A
Stem Cell Res Ther; 2024 Apr; 15(1):111. PubMed ID: 38644499
[TBL] [Abstract][Full Text] [Related]
18. A risk score system for stratifying the risk of relapse in B cell acute lymphocytic leukemia patients after allogenic stem cell transplantation.
Cao LQ; Zhou Y; Liu YR; Xu LP; Zhang XH; Wang Y; Chen H; Chen YH; Wang FR; Han W; Sun YQ; Yan CH; Tang FF; Mo XD; Liu KY; Fan QZ; Chang YJ; Huang XJ
Chin Med J (Engl); 2021 Mar; 134(10):1199-1208. PubMed ID: 33734137
[TBL] [Abstract][Full Text] [Related]
19. The paradigm of total body irradiation in acute lymphoblastic leukaemia: Therapeutic effectiveness versus the challenges of toxicity.
Echecopar C; Del Val Rey I; Galán-Gómez V; González-Pérez C; Mozo Del Castillo Y; González Martínez B; Pérez-Martínez A
An Pediatr (Engl Ed); 2024 Apr; 100(4):259-267. PubMed ID: 38548564
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic Stem Cell Transplantation in Refractory Acute Myeloid Leukaemia.
Bono R; Sapienza G; Tringali S; Rotolo C; Patti C; Mulè A; Calafiore V; Santoro A; Castagna L
Cells; 2024 Apr; 13(9):. PubMed ID: 38727291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
